Product
CAV Regimen
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
Venetoclax, Cladribine Plus Low-dose Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia: a Multicenter, Randomized, Controlled StudyStatus: Recruiting, Estimated PCD: 2024-10-01